4.7 Meeting Abstract

Drotrecogin alfa (activated) improves in-hospital and 90-day survival in patients with severe sepsis and community-acquired pneumonia

Journal

CHEST
Volume 124, Issue 4, Pages 91S-91S

Publisher

AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.124.5.1789

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available